CAH
Price
$206.09
Change
+$1.78 (+0.87%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
48.96B
76 days until earnings call
Intraday BUY SELL Signals
MCK
Price
$846.24
Change
+$5.49 (+0.65%)
Updated
Nov 13 closing price
Capitalization
104.45B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CAH vs MCK

Header iconCAH vs MCK Comparison
Open Charts CAH vs MCKBanner chart's image
Cardinal Health
Price$206.09
Change+$1.78 (+0.87%)
Volume$17.65K
Capitalization48.96B
McKesson
Price$846.24
Change+$5.49 (+0.65%)
Volume$712.79K
Capitalization104.45B
CAH vs MCK Comparison Chart in %
CAH
Daily Signal:
Gain/Loss:
MCK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CAH vs. MCK commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Buy and MCK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CAH: $206.06 vs. MCK: $846.24)
Brand notoriety: CAH: Not notable vs. MCK: Notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 88% vs. MCK: 103%
Market capitalization -- CAH: $48.96B vs. MCK: $104.45B
CAH [@Medical Distributors] is valued at $48.96B. MCK’s [@Medical Distributors] market capitalization is $104.45B. The market cap for tickers in the [@Medical Distributors] industry ranges from $104.45B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 3 FA rating(s) are green whileMCK’s FA Score has 3 green FA rating(s).

  • CAH’s FA Score: 3 green, 2 red.
  • MCK’s FA Score: 3 green, 2 red.
According to our system of comparison, MCK is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 4 TA indicator(s) are bullish while MCK’s TA Score has 2 bullish TA indicator(s).

  • CAH’s TA Score: 4 bullish, 4 bearish.
  • MCK’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CAH is a better buy in the short-term than MCK.

Price Growth

CAH (@Medical Distributors) experienced а +4.08% price change this week, while MCK (@Medical Distributors) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.80%. For the same industry, the average monthly price growth was -2.36%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CAH is expected to report earnings on Jan 29, 2026.

MCK is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Medical Distributors (-0.80% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($104B) has a higher market cap than CAH($49B). CAH has higher P/E ratio than MCK: CAH (31.08) vs MCK (26.45). CAH YTD gains are higher at: 75.239 vs. MCK (48.010). MCK has higher annual earnings (EBITDA): 5.19B vs. CAH (3.11B). CAH has less debt than MCK: CAH (8.53B) vs MCK (9.93B). MCK has higher revenues than CAH: MCK (378B) vs CAH (223B).
CAHMCKCAH / MCK
Capitalization49B104B47%
EBITDA3.11B5.19B60%
Gain YTD75.23948.010157%
P/E Ratio31.0826.45117%
Revenue223B378B59%
Total CashN/A2.42B-
Total Debt8.53B9.93B86%
FUNDAMENTALS RATINGS
CAH vs MCK: Fundamental Ratings
CAH
MCK
OUTLOOK RATING
1..100
2723
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
410
P/E GROWTH RATING
1..100
1866
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (17) in the Medical Distributors industry is somewhat better than the same rating for CAH (77). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is in the same range as MCK (4). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as MCK (99). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's Price Growth Rating (4) in the Medical Distributors industry is in the same range as MCK (10). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's P/E Growth Rating (18) in the Medical Distributors industry is somewhat better than the same rating for MCK (66). This means that CAH’s stock grew somewhat faster than MCK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHMCK
RSI
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
43%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
47%
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
65%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
39%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 5 days ago
65%
Bullish Trend 9 days ago
65%
Declines
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
38%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
45%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signal:
Gain/Loss:
MCK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
COPY12.430.07
+0.57%
Tweedy, Browne Insider + Value ETF
TPYP35.540.10
+0.28%
Tortoise North American Pipeline
MSTB40.760.03
+0.08%
LHA Market State Tactical Beta ETF
EMSF31.19-0.01
-0.02%
Matthews Emerging Markets Sus Fut ActETF
SCHP26.88-0.05
-0.19%
Schwab US TIPS ETF™

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-0.24%
MCK - CAH
54%
Loosely correlated
-1.83%
COR - CAH
53%
Loosely correlated
-0.45%
HSIC - CAH
15%
Poorly correlated
-0.52%
YI - CAH
14%
Poorly correlated
-0.20%
SHTDF - CAH
12%
Poorly correlated
N/A
More

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
-1.83%
COR - MCK
74%
Closely correlated
-0.45%
CAH - MCK
54%
Loosely correlated
-0.24%
HSIC - MCK
12%
Poorly correlated
-0.52%
SHTDF - MCK
9%
Poorly correlated
N/A
YI - MCK
6%
Poorly correlated
-0.20%
More